# Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/PCVX/vaxcyte-to-present-at-the-25th-annual-needham-virtual-healthcare-conference
Ticker: PCVX
Company: Vaxcyte
Source: Vaxcyte
Published: 2026-04-07 20:05 EST
Original Source URL: https://investors.vaxcyte.com
## Summary

SAN CARLOS, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Tuesday, April 14, 2026 at 2:15

## Article Body
SAN CARLOS, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Tuesday, April 14, 2026 at 2:15
## Recent Company News
- 2026-06-02 20:05 EST — [Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults](https://biopharmsignal.com/news/PCVX/vaxcyte-doses-first-participant-in-phase-1-study-evaluating-vax-a1-for-the-prevention-of-disease-caused-by-group-a-streptococcus-in-healthy-adults) — Source: Vaxcyte
- 2026-05-06 20:05 EST — [Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/PCVX/vaxcyte-reports-first-quarter-2026-financial-results-and-provides-business-update) — Source: Vaxcyte
- 2026-04-07 20:05 EST — [Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/PCVX/vaxcyte-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: Vaxcyte
- 2026-03-23 12:30 EST — [Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults](https://biopharmsignal.com/news/PCVX/vaxcyte-completes-enrollment-of-opus-1-and-opus-2-phase-3-trials-evaluating-vax-31-for-the-prevention-of-invasive-pneumococcal-disease-and-pneumonia-in-adults) — Source: Vaxcyte
- 2026-03-18 23:34 EST — [Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate](https://biopharmsignal.com/news/PCVX/positive-vax-31-phase-1-2-adult-data-published-in-the-lancet-infectious-diseases-highlight-best-in-class-potential-of-vaxcyte-s-31-valent-pneumococcal-conjugate-vaccine-pcv-candidate) — Source: Vaxcyte
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)